Section 6.1: Federal vs. Texas Controlled Substances Schedules

Section 6.1: Federal vs. Texas Controlled Substances Schedules

Introduction to Controlled Substance Scheduling

The classification of controlled substances is the bedrock of pharmacy jurisprudence, establishing strict guidelines for the manufacturing, distribution, prescribing, and dispensing of medications with potential for abuse or dependence. At the federal level, this framework is governed by the Controlled Substances Act (CSA) of 1970, which is codified in Title 21 of the United States Code (USC) and administered by the Drug Enforcement Administration (DEA). In the State of Texas, the regulatory architecture is defined by the Texas Controlled Substances Act, found in Chapter 481 of the Texas Health and Safety Code. While the state and federal scheduling systems are substantially aligned, the Texas MPJE frequently tests key discrepancies where Texas law is more restrictive or diverges from federal scheduling. Under the doctrine of federal preemption, when state and federal laws conflict, the stricter law must always be followed by the practicing pharmacist.

Constitutional and Statutory Basis: The Dual Sovereign System

Pharmacy practice operates under a dual sovereign system, meaning that pharmacists must simultaneously comply with federal statutes and the laws of the state in which they practice. Under the Supremacy Clause of the U.S. Constitution, federal law generally preempts state law when there is a direct conflict. However, in the realm of controlled substances, federal law explicitly permits states to enact regulations that are more stringent than federal rules. Consequently, if Texas schedules a drug in a more restrictive category than the federal government (or controls a drug that is federally non-controlled), the pharmacist must adhere to the stricter Texas classification. Conversely, if Texas were to enact a law that was less restrictive than federal law (which it does not), federal law would preempt it, and the pharmacist would still be bound by the stricter federal standard.

Scheduling Authority: Who Decides?

At the federal level, the authority to add, delete, or reschedule a substance is vested in the United States Attorney General, who typically delegates this responsibility to the Administrator of the DEA. Before scheduling a drug, the Attorney General must request a scientific and medical evaluation from the Secretary of the Department of Health and Human Services (HHS), which is conducted by the Food and Drug Administration (FDA). The HHS recommendation is binding on the Attorney General regarding scientific and medical matters.

In Texas, the scheduling authority is structured differently:

1. The DSHS Commissioner: Under Texas Health and Safety Code § 481.034, the Commissioner of the Texas Department of State Health Services (DSHS) is empowered to administer and make changes to the state schedules of controlled substances. The Commissioner can add, delete, or reschedule substances based on their abuse potential, scientific evidence of pharmacological effects, history and current patterns of abuse, and public health risk.
2. The TSBP Role: While the DSHS Commissioner has the primary authority to initiate scheduling changes, the Texas State Board of Pharmacy (TSBP) holds significant veto power. The DSHS Commissioner cannot establish or modify a schedule if the TSBP objects. This division of power ensures that the practical implications for pharmacy practice are thoroughly vetted by the state's pharmacy regulatory board before any scheduling changes take effect.

Key Scheduled Differences: The Fioricet Trap

Perhaps the most famous discrepancy between federal and Texas controlled substances schedules concerns products containing butalbital, acetaminophen, and caffeine.

• Fioricet: Fioricet is a combination product containing butalbital (50 mg), acetaminophen (325 mg), and caffeine (40 mg). Under federal regulations, Fioricet is classified as an exempt prescription drug (non-controlled legend drug). The federal exemption was granted because the ratio of acetaminophen to butalbital was historically deemed sufficient to deter abuse.
• Fiorinal: Fiorinal is a similar combination product containing butalbital (50 mg), aspirin (325 mg), and caffeine (40 mg). Unlike Fioricet, Fiorinal is classified as a Schedule III controlled substance under both federal and Texas laws.
• The Texas Override: Under the Texas Controlled Substances Act, the state did not adopt the federal exemption for Fioricet. Consequently, in Texas, Fioricet is a Schedule III controlled substance.
• Practical Application: This difference represents a major trap on the Texas MPJE. In Texas, a prescription for Fioricet must comply with all Schedule III requirements: it must be written on a valid prescription form, is subject to a 5-refill or 6-month limit (whichever comes first), must be reported to the Prescription Monitoring Program (PMP), and requires the prescriber's DEA number. It must also be stored and inventoried as a Schedule III substance.

Key Scheduled Differences: Schedule V Prescription Requirement

Another critical difference between federal law and Texas law involves the dispensing of Schedule V controlled substances, particularly cough preparations containing small quantities of codeine (e.g., Robitussin AC, promethazine with codeine).

• Federal Rule: Under federal law, certain Schedule V controlled substances may be sold over-the-counter (OTC) without a prescription, provided that the distribution is made by a pharmacist, the purchaser is at least 18 years of age, the quantity is limited (e.g., no more than 120 mL or 4 ounces of a codeine-containing preparation in a 48-hour period), and the transaction is recorded in a bound record book.
• Texas Rule: The Texas Controlled Substances Act strictly prohibits the OTC sale of any controlled substance. In Texas, all Schedule V controlled substances require a valid prescription to be dispensed. Pharmacists are prohibited from selling codeine cough syrups or any other Schedule V substances without a prescription, regardless of the quantity or the purchaser's age.

Summary Table: Federal vs. Texas Scheduling Distinctions

Scheduling of Cannabidiol (CBD) and Hemp Products in Texas

The legal status of cannabis and cannabidiol (CBD) has evolved rapidly at both state and federal levels. Following the passage of the federal Agriculture Improvement Act of 2018 (the Farm Bill), hemp and hemp-derived products containing less than 0.3% delta-9 tetrahydrocannabinol (THC) on a dry-weight basis were removed from the definition of marijuana and descheduled federally.

• Epidiolex: Epidiolex, an FDA-approved purified CBD oral solution used to treat rare seizure disorders, was initially placed in Schedule V. In 2020, the DEA descheduled Epidiolex entirely. To maintain consistency, the DSHS Commissioner issued an order descheduling Epidiolex in Texas.
• Hemp and Retail CBD: Texas subsequently aligned its statutes with federal law by legalizing the production and sale of consumable hemp products containing less than 0.3% delta-9 THC. However, the manufacturing and sale of smokable hemp products remain illegal within Texas borders. Furthermore, any cannabis product containing more than 0.3% delta-9 THC is classified as marijuana (a Schedule I equivalent in Texas, except under the highly restricted Texas Compassionate Use Program, which allows low-THC cannabis for specific medical conditions).

Exam Traps & Jurisprudence Nuances

When preparing for the Texas MPJE, keep the following traps in mind:

1. The Combination Drug Trap: Always look closely at the active ingredients. If a question describes a product containing butalbital and acetaminophen, it is Fioricet, which is C-III in Texas but non-controlled federally. If it contains butalbital and aspirin, it is Fiorinal, which is C-III under both laws.
2. The "Federal Exemption" Trick: An exam question might ask: "Under federal law, which of the following is exempt from controlled substance scheduling?" The answer is Fioricet. However, if the question asks: "Under Texas law, which of the following is exempt?" Fioricet is NOT the answer, because it is a Schedule III controlled substance in Texas.
3. The OTC Schedule V Misconception: Do not select any answer option that suggests a pharmacist in Texas can sell a codeine-containing cough syrup over the counter without a prescription. Even though federal law allows this, Texas law is more restrictive and completely bans OTC sales of Schedule V controlled substances.